Publication | Closed Access

Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages

InflammationPeripheral Benzodiazepine ReceptorsMedicineSepsisHepatotoxicityPharmacotherapyPharmacologyDrug-induced Liver InjuryP38 Inhibition